Cargando…
Current Epidemiological Assessment of Bancroftian Filariasis in Tanga Region, Northeastern Tanzania
Background. Tanzania started a countrywide lymphatic filariasis elimination programme in 2000 adopting the mass drug administration (MDA) strategy. The drug used for the programme was the combination of ivermectin and albendazole. However, there is limited information on the current epidemiological...
Autores principales: | Mshana, Happyness J., Baraka, Vito, Misinzo, Gerald, Makunde, Williams H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5168450/ https://www.ncbi.nlm.nih.gov/pubmed/28050171 http://dx.doi.org/10.1155/2016/7408187 |
Ejemplares similares
-
Treatment of co-infection with bancroftian filariasis and onchocerciasis: a safety and efficacy study of albendazole with ivermectin compared to treatment of single infection with bancroftian filariasis
por: Makunde, William H, et al.
Publicado: (2003) -
Current Evidence on the Use of Antifilarial Agents in the Management of Bancroftian Filariasis
por: Fernando, Sumadhya Deepika, et al.
Publicado: (2011) -
Lymphatic filariasis control in Tanga Region, Tanzania: status after eight rounds of mass drug administration
por: Simonsen, Paul E, et al.
Publicado: (2014) -
Mapping of Bancroftian Filariasis in Cameroon: Prospects for Elimination
por: Nana-Djeunga, Hugues C., et al.
Publicado: (2015) -
The Burden of Bancroftian Filariasis in Nigeria: A Review
por: Hussaini, Adamu, et al.
Publicado: (2020)